肺癌基因治疗研究进展  

Progress in pulmonary carcinoma gene therapy

作　　者：何祥梁[1] 何东华[2] 

机构地区：[1]广州第一军医大学珠江医院呼吸科,广东广州510282 [2]中山医科大学达安基因诊断中心,广东广州510120

出　　处：《中国病理生理杂志》2002年第11期1447-1450,共4页Chinese Journal of Pathophysiology

摘　　要：The high morbidity and mortality of pulmonary carcinoma,especially in male patient,are still the unsolved problems. Recently,more and more reports showed that gene therapy could have potential application in the treatment of the disease. In this article,some progresses in the gene therapy of pulmonary carcinoma, such as tumor suppressor gene,drug sensitive gene,antisense gene,multi-drug resistance gene,immune gene as well as anti-angiogenesis gene, were discussed.The high morbidity and mortality of pulmonary carcinoma,especially in male patient,are still the unsolved problems. Recently,more and more reports showed that gene therapy could have potential application in the treatment of the disease. In this article,some progresses in the gene therapy of pulmonary carcinoma, such as tumor suppressor gene,drug sensitive gene,antisense gene,multi-drug resistance gene,immune gene as well as anti-angiogenesis gene, were discussed.

关 键 词：肺癌 基因治疗 研究进展 抑癌基因 反义基因 

分 类 号：R730.5[医药卫生—肿瘤] R734.[医药卫生—临床医学]